Vivek Ra­maswamy ramps up biotech start­up #14 — this time work­ing on a gene ther­a­py for sick­le cell dis­ease and β-tha­lassemia

Vivek Ra­maswamy’s Roivant Sci­ences has nabbed its lat­est clin­i­cal-stage pro­gram for biotech start­up #14 — Aru­vant — and this time they’re go­ing up against a cou­ple of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER